Quarterly Call Option Transactions in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during . The information is specifically focused on institutions that hold call options of Keros Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 0 | 78,300 | 78,300 | — | 78,300 | |||
| Q1 2022 | 2,200 | 26,200 | 28,400 | 24,900 | 0 | 24,900 | 3,500 | |
| Q2 2022 | — | 0 | 13,700 | 13,700 | -13,700 | |||
| Q3 2022 | 8,300 | 63,400 | 71,700 | — | 71,700 | |||
| Q4 2022 | 0 | 1,100 | 1,100 | 10,300 | 0 | 10,300 | -9,200 | |
| Q1 2023 | 6,200 | 0 | 6,200 | 47,000 | 0 | 47,000 | -40,800 | |
| Q2 2023 | — | 400 | 0 | 400 | -400 | |||
| Q3 2023 | — | — | 0 | |||||
| Q4 2023 | 900 | 0 | 900 | 900 | 0 | 900 | 0 | |
| Q1 2024 | 10,800 | 35,300 | 46,100 | — | 46,100 | |||
| Q2 2024 | 5,900 | 10,000 | 15,900 | 11,100 | 0 | 11,100 | 4,800 | |
| Q3 2024 | 17,000 | 41,100 | 58,100 | — | 58,100 | |||